Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1995 1
1997 1
1999 1
2000 1
2001 1
2003 1
2004 1
2005 1
2006 1
2007 1
2008 1
2010 3
2011 1
2012 4
2014 2
2015 4
2016 4
2017 3
2018 5
2019 13
2020 14
2021 14
2022 4
2023 5
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

87 results

Results by year

Filters applied: . Clear all
Page 1
Plasma p-tau231: a new biomarker for incipient Alzheimer's disease pathology.
Ashton NJ, Pascoal TA, Karikari TK, Benedet AL, Lantero-Rodriguez J, Brinkmalm G, Snellman A, Schöll M, Troakes C, Hye A, Gauthier S, Vanmechelen E, Zetterberg H, Rosa-Neto P, Blennow K. Ashton NJ, et al. Among authors: hye a. Acta Neuropathol. 2021 May;141(5):709-724. doi: 10.1007/s00401-021-02275-6. Epub 2021 Feb 14. Acta Neuropathol. 2021. PMID: 33585983 Free PMC article.
A genome-wide association study of plasma phosphorylated tau181.
Lord J, Zettergren A, Ashton NJ, Karikari TK, Benedet AL, Simrén J; Alzheimer's Disease Neuroimaging Initiative; Hye A, Aarsland D; AddNeuroMed consortium; Blennow K, Zetterberg H, Proitsi P. Lord J, et al. Among authors: hye a. Neurobiol Aging. 2021 Oct;106:304.e1-304.e3. doi: 10.1016/j.neurobiolaging.2021.04.018. Epub 2021 May 4. Neurobiol Aging. 2021. PMID: 34119372 Free article.
A multicentre validation study of the diagnostic value of plasma neurofilament light.
Ashton NJ, Janelidze S, Al Khleifat A, Leuzy A, van der Ende EL, Karikari TK, Benedet AL, Pascoal TA, Lleó A, Parnetti L, Galimberti D, Bonanni L, Pilotto A, Padovani A, Lycke J, Novakova L, Axelsson M, Velayudhan L, Rabinovici GD, Miller B, Pariante C, Nikkheslat N, Resnick SM, Thambisetty M, Schöll M, Fernández-Eulate G, Gil-Bea FJ, López de Munain A, Al-Chalabi A, Rosa-Neto P, Strydom A, Svenningsson P, Stomrud E, Santillo A, Aarsland D, van Swieten JC, Palmqvist S, Zetterberg H, Blennow K, Hye A, Hansson O. Ashton NJ, et al. Among authors: hye a. Nat Commun. 2021 Jun 7;12(1):3400. doi: 10.1038/s41467-021-23620-z. Nat Commun. 2021. PMID: 34099648 Free PMC article.
A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer's disease.
Ashton NJ, Nevado-Holgado AJ, Barber IS, Lynham S, Gupta V, Chatterjee P, Goozee K, Hone E, Pedrini S, Blennow K, Schöll M, Zetterberg H, Ellis KA, Bush AI, Rowe CC, Villemagne VL, Ames D, Masters CL, Aarsland D, Powell J, Lovestone S, Martins R, Hye A. Ashton NJ, et al. Among authors: hye a. Sci Adv. 2019 Feb 6;5(2):eaau7220. doi: 10.1126/sciadv.aau7220. eCollection 2019 Feb. Sci Adv. 2019. PMID: 30775436 Free PMC article.
Urinary metabolic phenotyping for Alzheimer's disease.
Kurbatova N, Garg M, Whiley L, Chekmeneva E, Jiménez B, Gómez-Romero M, Pearce J, Kimhofer T, D'Hondt E, Soininen H, Kłoszewska I, Mecocci P, Tsolaki M, Vellas B, Aarsland D, Nevado-Holgado A, Liu B, Snowden S, Proitsi P, Ashton NJ, Hye A, Legido-Quigley C, Lewis MR, Nicholson JK, Holmes E, Brazma A, Lovestone S. Kurbatova N, et al. Among authors: hye a. Sci Rep. 2020 Dec 10;10(1):21745. doi: 10.1038/s41598-020-78031-9. Sci Rep. 2020. PMID: 33303834 Free PMC article.
Metabolic phenotyping reveals a reduction in the bioavailability of serotonin and kynurenine pathway metabolites in both the urine and serum of individuals living with Alzheimer's disease.
Whiley L, Chappell KE, D'Hondt E, Lewis MR, Jiménez B, Snowden SG, Soininen H, Kłoszewska I, Mecocci P, Tsolaki M, Vellas B, Swann JR, Hye A, Lovestone S, Legido-Quigley C, Holmes E; AddNeuroMed consortium. Whiley L, et al. Among authors: hye a. Alzheimers Res Ther. 2021 Jan 9;13(1):20. doi: 10.1186/s13195-020-00741-z. Alzheimers Res Ther. 2021. PMID: 33422142 Free PMC article.
Dementia with Lewy bodies - a clinicopathological update.
Bencze J, Seo W, Hye A, Aarsland D, Hortobágyi T. Bencze J, et al. Among authors: hye a. Free Neuropathol. 2020 Feb 18;1:7. doi: 10.17879/freeneuropathology-2020-2613. eCollection 2020 Jan. Free Neuropathol. 2020. PMID: 37283665 Free PMC article.
Update on biomarkers for amyloid pathology in Alzheimer's disease.
Ashton NJ, Schöll M, Heurling K, Gkanatsiou E, Portelius E, Höglund K, Brinkmalm G, Hye A, Blennow K, Zetterberg H. Ashton NJ, et al. Among authors: hye a. Biomark Med. 2018 Jul;12(7):799-812. doi: 10.2217/bmm-2017-0433. Epub 2018 Jun 15. Biomark Med. 2018. PMID: 29902934 Review.
Plasma transthyretin as a candidate marker for Alzheimer's disease.
Velayudhan L, Killick R, Hye A, Kinsey A, Güntert A, Lynham S, Ward M, Leung R, Lourdusamy A, To AW, Powell J, Lovestone S. Velayudhan L, et al. Among authors: hye a. J Alzheimers Dis. 2012;28(2):369-75. doi: 10.3233/JAD-2011-110611. J Alzheimers Dis. 2012. PMID: 22002789 Free article.
87 results